Skip to Main content Skip to Navigation
Journal articles

Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: Synthesis and in vitro anti-mycobacterial activity.

Abstract : A series of N(1)-(4-substituted-benzyl)-pyrimidines were synthesized as potential inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis (TMPKmt). Key SAR parameters included the chain length substitution in para position of the benzyl ring, the functional group terminating the alkyl chain, and the substituent on the C-5 pyrimidine ring. Synthesized molecules were assayed against both recombinant enzyme and mycobacteria cultures. The most potent compounds have K(i) values in the micromolar range and an MIC(50) of 50microg/mL against Mycobacterium bovis. These results will guide the design of a new generation of lead compounds.
Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-00307723
Contributor : Sylvie Pochet <>
Submitted on : Tuesday, July 29, 2008 - 12:30:12 PM
Last modification on : Monday, January 13, 2020 - 5:08:08 PM

Identifiers

Collections

Citation

Cécile Gasse, Dominique Douguet, Valérie Huteau, Gilles Marchal, Hélène Munier-Lehmann, et al.. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: Synthesis and in vitro anti-mycobacterial activity.. Bioorganic and Medicinal Chemistry, Elsevier, 2008, 16 (11), pp.6075-85. ⟨10.1016/j.bmc.2008.04.045⟩. ⟨pasteur-00307723⟩

Share

Metrics

Record views

277